AzTrials
AzTrials

Lateral EpicondylitisPCNF-BrEpiNCT07894718

Effect of Ultrasound-Guided Posterior Cutaneous Nerve of the Forearm Epicondylar Branch Block on Pain and Function in Lateral Epicondylitis (PCNF-BrEpi)

A study testing Ultrasound-guided triamcinolone injection, Ultrasound-guided PCNF-BrEpi block and Conventional therapy (home exercise program and epicondylitis band) in people with Lateral Epicondylitis, run by Gaziler Physical Medicine and Rehabilitation Education and Research Hospital at 1 site in Turkey (Türkiye).

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

This study evaluates the effect of an ultrasound-guided posterior cutaneous nerve of the forearm epicondylar branch block on pain and functional status in patients with lateral epicondylitis. The procedure is performed using ultrasound guidance. Read more about this study

Who is it for?
Ages 18 to 65 years
Conditions the study is for
Lateral Epicondylitis
What is being tested?
Ultrasound-guided triamcinolone injection, Ultrasound-guided PCNF-BrEpi block and Conventional therapy (home exercise program and epicondylitis band)
Could I receive a placebo?
No, everyone receives an active treatment
How many people
84 participants
Where
1 siteTurkey (Türkiye)
Study dates
25 Oct 2025to 25 Dec 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Age between 18 and 65 years
  • Symptom duration of at least 6 weeks
  • Clinical and ultrasonographic diagnosis of lateral epicondylitis (based on history, physical examination and provocation tests)
  • Visual Analog Scale (VAS) pain score of 4 or higher
  • Signed informed consent form

Who cannot join

  • Injection or trauma to the affected elbow region within the last 3 months
  • Cervical radicular pain, median or ulnar entrapment neuropathy, or medial epicondylitis
  • Use of anticoagulant therapy
  • Pregnancy or breastfeeding
  • Psychiatric disorder or cognitive impairment preventing completion of questionnaires and assessment scales
  • History of allergy to the solutions to be used (triamcinolone or lidocaine)
Show all 10Show fewer
  • History of upper extremity surgery or fracture
  • Connective tissue disease (e.g., rheumatoid arthritis, dermatomyositis)
  • Diabetes mellitus, fibromyalgia, or polyneuropathy
  • History of active malignancy

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Turkey (Türkiye)1 site, 1 recruiting
  • Gaziler Physical Medicine and Rehabilitation Training and Research Hospital

    Ankara, Ankara, Çankaya, 06800

    Fatma ÖZCAN, Associate Professor Doctor, 0507 868 95 45 ext. 03122911000, fatma_yumus@hotmail.com

    Recruiting

Other trials in Turkey (Türkiye)

About this study

Official title: EFFECT OF ULTRASOUND-GUİDED POSTERİOR CUTANEOUS NERVE OF THE FOREARM EPİCONDYLAR BRANCH BLOCK ON PAİN AND FUNCTİONAL STATUS İN PATİENTS WİTH LATERAL EPİCONDYLİTİS

This study evaluates the effect of an ultrasound-guided posterior cutaneous nerve of the forearm epicondylar branch block on pain and functional status in patients with lateral epicondylitis. The procedure is performed using ultrasound guidance. Pain and elbow function are assessed before and after the intervention to determine whether this nerve block can improve pain and functional outcomes in patients with lateral epicondylitis.

Being tested
Ultrasound-guided triamcinolone injection, Ultrasound-guided PCNF-BrEpi block, Conventional therapy (home exercise program and epicondylitis band)
Keywords
Lateral Epicondylitis
Medical subject headings
Tennis Elbow

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Ultrasound-guided triamcinolone injectionDrug

    Single-point injection of 1 mL triamcinolone into the common extensor tendon enthesis at the most tender point of the lateral epicondyle under ultrasound guidance (in-plane technique, 25-gauge needle), with the patient supine, shoulder adducted, elbow flexed 90 degrees and wrist pronated.

  • Ultrasound-guided PCNF-BrEpi blockProcedure or surgery

    Ultrasound-guided nerve block of the epicondylar branch of the posterior cutaneous nerve of the forearm with 1 mL of 2% lidocaine. Nerve localization is confirmed with an electrical nerve stimulator before injection.

  • Conventional therapy (home exercise program and epicondylitis band)Other

    Standardized home exercise program given by the same physician: manual resistance strengthening (3 sets of 10 repetitions), static stretching of the extensor carpi radialis brevis (3 x 30 seconds before and after strengthening) and eccentric wrist exercises (3 sets of 10 repetitions, progressively increased resistance), performed once daily every day, plus use of an epicondylitis band. Participants will be followed by weekly phone calls. NSAIDs are not allowed during the first month; paracetamol is permitted for pain.

Study groups in NCT07894718
Study groupRoleWhat they receive
Conventional Therapy + Steroid InjectionActive comparatorParticipants will receive conventional therapy (home exercise program and epicondylitis band) plus a single ultrasound-guided injection of 1 mL triamcinolone into the common extensor tendon origin (enthesis) at the lateral epicondyle, using an in-plane technique with a 25-gauge needle.
Receives: Drug: Ultrasound-guided triamcinolone injection; Other: Conventional therapy (home exercise program and epicondylitis band)
Conventional Therapy + Steroid Injection + PCNF-BrEpi BlockExperimentalParticipants will receive conventional therapy (home exercise program and epicondylitis band) plus a single ultrasound-guided injection of 1 mL triamcinolone into the common extensor tendon origin at the lateral epicondyle. In the same session and position, an ultrasound-guided block of the epicondylar branch of the posterior cutaneous nerve of the forearm (PCNF-BrEpi) will be performed with 1 mL of 2% lidocaine after confirming the nerve with an electrical nerve stimulator.
Receives: Drug: Ultrasound-guided triamcinolone injection; Procedure: Ultrasound-guided PCNF-BrEpi block; Other: Conventional therapy (home exercise program and epicondylitis band)
Conventional TherapyActive comparatorParticipants will receive conventional therapy only, consisting of a standardized home exercise program (strengthening, static stretching and eccentric exercises, once daily, every day) and an epicondylitis band.
Receives: Other: Conventional therapy (home exercise program and epicondylitis band)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Patient-Rated Tennis Elbow Evaluation (PRTEE)

    PRTEE is a patient-reported outcome measure used to assess pain and functional disability related to tennis elbow.

    Measured: At baseline, 1 month, and 3 months after treatment initiation

Secondary outcomes (5)
  1. Visual Analog Scale

    Visual Analog Scale used to assess pain intensity.

    Measured: At baseline, 1 month, and 3 months after treatment initiation

  2. Quick Disabilities of the Arm, Shoulder and Hand(QuickDASH)

    QuickDASH is a patient-reported outcome measure used to assess upper extremity physical function and symptoms.

    Measured: At baseline, 1 month, and 3 months after treatment initiation

  3. Common Extensor Tendon Thickness Measured by Ultrasonography

    Thickness of the common extensor tendon measured by ultrasonography.

    Measured: At baseline, 1 month, and 3 months after treatment initiation

  4. Hand Grip Strength Measured by Dynamometry

    Hand grip strength measured using a hand dynamometer.

    Measured: At baseline, 1 month, and 3 months after treatment initiation

  5. Global Rating of Treatment Outcome

    Patient's global assessment of the overall treatment outcome.

    Measured: At baseline, 1 month, and 3 months after treatment initiation

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted26 Oct 2026
  2. Study start25 Oct 2025
  3. Primary completion25 Dec 2026 (estimated)
  4. Study completion25 Dec 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
84 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07894718
Sponsor's protocol ID
2024-KAEK-20
Acronym
PCNF-BrEpi
Status last verified
Aug 2026
First submitted
19 Oct 2026
Last updated
26 Oct 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Individual participant data will not be shared publicly due to patient confidentiality. Data may be made available by the corresponding author upon reasonable request, subject to ethics committee approval.

Publications

  • Maida E, Chiavaras MM, Jelsing EJ, O'Driscoll SW, Pawlina W, Smith J. Sonographic Visualization of the Posterior Cutaneous Nerve of the Forearm: Technique and Validation Using Perineural Injections in a Cadaveric Model. J Ultrasound Med. 2017 Aug;36(8):1627-1637. doi: 10.7863/ultra.16.08027. Epub 2017 Apr 8.

    PubMed 28390161
  • Koldas Dogan S, Ay S, Evcik D, Baser O. Adaptation of Turkish version of the questionnaire Quick Disability of the Arm, Shoulder, and Hand (Quick DASH) in patients with carpal tunnel syndrome. Clin Rheumatol. 2011 Feb;30(2):185-91. doi: 10.1007/s10067-010-1470-y. Epub 2010 Apr 22.

    PubMed 20411289
  • Altan L, Ercan I, Konur S. Reliability and validity of Turkish version of the patient rated tennis elbow evaluation. Rheumatol Int. 2010 Jun;30(8):1049-54. doi: 10.1007/s00296-009-1101-6. Epub 2009 Aug 26.

    PubMed 19707766
  • Ozmen T, Koparal SS, Karatas O, Eser F, Ozkurt B, Gafuroglu TU. Comparison of the clinical and sonographic effects of ultrasound therapy, extracorporeal shock wave therapy, and Kinesio taping in lateral epicondylitis. Turk J Med Sci. 2021 Feb 26;51(1):76-83. doi: 10.3906/sag-2001-79.

    PubMed 32682361
  • Umapathy S, Miller M, Chen YT. Novel Ultrasound-Guided Radiofrequency Ablation of the Epicondylar Branch of the Posterior Cutaneous Nerve of the Forearm for Recalcitrant Lateral Epicondylosis. Cureus. 2024 May 28;16(5):e61222. doi: 10.7759/cureus.61222. eCollection 2024 May.

    PubMed 38939254

Questions about this trial

What is this clinical trial studying?

A study testing Ultrasound-guided triamcinolone injection, Ultrasound-guided PCNF-BrEpi block and Conventional therapy (home exercise program and epicondylitis band) in people with Lateral Epicondylitis, run by Gaziler Physical Medicine and Rehabilitation Education and Research Hospital at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 10 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 26 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Each site lists its own contact: choose the nearest one under Trial locations. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Patient-Rated Tennis Elbow Evaluation (PRTEE) (time frame: At baseline, 1 month, and 3 months after treatment initiation). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07894718, which also lists 5 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Oct 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in